Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Family Medicine

Diabetes Mellitus, Type 1 Clinical Trials


A listing of Diabetes Mellitus, Type 1 medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Tuscon : University of Arizona

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Chandler : Investigational Site Number 840156

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Arkansas

Little Rock : Investigational Site Number 840177

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

California

Anaheim : Anaheim Clinical Trials (ACT)

Patients with Type I Diabetes needed for a clinical research trial.

Duarte : City of Hope

Detection of Human Beta Cell Death in T1DM Methylation-Specific PCR

Duarte : City of Hope

Long-Term Follow-Up of Islet Transplant Recipients

Duarte : City of Hope

TrialNet TN-01: Trialnet Natural History Study of the Development of Type I Diabetes

Escondido : AMCR Institute, Inc. Updated

A 52- Week Study to Compare the Glycemic Effects, Safety and Tolerability of A 52- Week Study to Evaluate the Safety and Efficacy of CBX129801 in Patients with Type 1 Diabetes With Mild to Moderate Diabetic Peripheral Neuropathy

Escondido : AMCR Institute, Inc. Updated

A Comparison of the Study Medication Once Daily at a Fixed Time to the Study Medication at a Variable Time in Patients With Diabetes Mellitus Type 1

Escondido : AMCR Institute, Inc.

Do you want to try a new glucose meter?

Escondido : AMCR Institute, Inc. Updated

Evaluation of Metabolic Outcomes and Safety of Hylenex Recombinant Used as Pre-administration Infusion Site Treatment in Patients With Diabetes Mellitus Type 1 on Insulin Pump

Escondido : AMCR Institute, Inc. Updated

The Natural History Study of the development of Type 1 Diabetes Screening Blood Test to Identify Increased Risk of Diabetes Mellitus Type 1

Los Angeles : Children’s Hospital of Los Angeles

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

Sacramento : Sutter Institute for Medical Research (SIMR)

Diabetes Type 1 - Genetics

San Diego : UCSD Rady Children’s Hospital

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

View More »

Anaheim : Anaheim Clinical Trials, LLC

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Bell Gardens : Investigational Site Number 840430

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Chula Vista : Profil Research Institute

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Chula Vista : Profil Institute For Clinical Research, Inc.

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Concord : John Muir Physician Network Clinical Research Center

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Escondido : Investigational Site Number 840131

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Escondido : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Fresno : Investigational Site Number 840140

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Fresno : Research Center of Fresno

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

Fresno : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Greenbrae : Investigational Site Number 840107

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Huntington Beach : Investigational Site Number 840149

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Irvine : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

La Jolla : Scripps Whittier Diabetes Institute

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

La Jolla : Investigational Site Number 840120

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

La Jolla : Investigational Site Number 840123

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

La Mesa : Investigational Site Number 840159

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Long Beach : Investigational Site Number 840114

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Long Beach : Health Care Partners Medical Group

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

Los Gatos : Private Practice - Richard Cherlin, MD.

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Los Gatos :

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Mission Hills : Investigational Site Number 840189

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Modesto : Sutter Gold Medical Foundation

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Salinas : Diabetes Care Center

A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections

San Diego : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2605541 Versus Insulin Glargine on Blood Sugar

San Diego : Va San Diego Healthcare System

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

San Diego : San Diego Clinical Trials

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

San Diego : Accelovance Inc.

Evaluation and Comparison of Noninvasive Blood Glucose Concentrations

San Diego : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

San Francisco : Monteagle Medical Center

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

San Mateo : Mills-Peninsula Health Services

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Stanford : Stanford University and Stanford Hospital & Clinics

Medtronic Treat to Range (TTR) Closed-Loop Control

Temecula : Investigational Site Number 840105

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Torrance : La Biomed Research Inst. At Harbor Ucla Med Ctr.

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Torrance : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Tustin : Investigational Site Number 840155

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Tustin : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Walnut Creek : Investigational Site Number 840115

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Walnut Creek : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Colorado

Aurora : University of Colorado, Barbara Davis Center for Childhood Diabetes

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

Aurora : University of Colorado, Barbara Davis Center for Childhood Diabetes

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Aurora : University of Colorado Hospital - Anschutz Outpatient Pavilion

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Aurora : Barbara Davis Center

Pramlintide in Adolescents With Type 1 Diabetes

Denver : Investigational Site Number 840160

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Denver : Investigational Site Number 840188

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Denver : Creekside Endocrine Associates, Inc.

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Longmont : Investigational Site Number 840143

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Connecticut

New Haven : Investigational Site Number 840196

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Delaware

Wilmington : Alfred I duPont Hospital

Statins in Children With Type 1 Diabetes and Hypercholesterolemia

District of Columbia

Washington : Investigational Site Number 840104

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Washington : George Washington University Medical Faculty Associates

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Florida

Miami : University of Miami School of Medicine

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

Miramar : Comprehensive Clinical Development - Miramar, FL

Overweight Men and Women Including Type 2 Diabetics

West Palm Beach : Metabolic Research Institute, Inc.

Do you have Type 1 Diabetes? Are your blood sugar levels still too high on your current insulin regimen?

View More »

Aventura : Innovative Medical Research of South Florida Inc.

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Boca Raton : Investigational Site Number 840152

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Bradenton : Investigational Site Number 840113

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

DeLand :

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Hialeah : Investigational Site Number 840102

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Hollywood : The Center for Diabetes and Endocrine Care

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Hollywood : Investigational Site Number 840134

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Jacksonville : Investigational Site Number 840185

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Jacksonville : Nemours Children's Clinic

Statins in Children With Type 1 Diabetes and Hypercholesterolemia

Miami : University of Miami Diabetes Research Institute

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Miami : Investigational Site Number 840118

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Miami : Investigational Site Number 840179

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Miami : Investigational Site Number 840126

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Miami : Investigational Site Number 840138

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

New Port Richey : Investigational Site Number 840117

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

North Miami Beach : Investigational Site Number 840183

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Orlando : Compass Research Phase 1, Llc

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Orlando : Investigational Site Number 840174

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Orlando : Orlando Diabetes & Endocrine Specialists, P.A.

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Orlando : Nemours Children's Clinic

Statins in Children With Type 1 Diabetes and Hypercholesterolemia

Oviedo : Investigational Site Number 840110

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Palm Harbor : Investigational Site Number 840178

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Pensacola : Nemours Children's Clinic

Statins in Children With Type 1 Diabetes and Hypercholesterolemia

Port Orange : Progressive Medical Research Pharmaseek

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Port Orange : Progressive Medical Research

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Tallahassee : Tallahassee Endocrine Associates

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Tampa : Investigational Site Number 840181

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Tampa : Diabetes and Hormonal Disease Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

West Palm Beach : Investigational Site Number 840420

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Georgia

Atlanta : Pinnacle Trials, Inc.

Do you have both Diabetes & Asthma?

Atlanta : Children’s Healthcare of Atlanta at Egleston

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

Atlanta : Atlanta Diabetes Associates

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

Atlanta : Emory's Children's Center

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Atlanta : Atlanta Diabetes Associates

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Atlanta : Investigational Site Number 840195

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Atlanta : Atlanta Diabetes Associates

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Decatur : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Roswell : Endocrine Research Solutions

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Hawaii

Honolulu : Investigational Site Number 840124

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Idaho

Idaho Falls : Rocky Mountain Diabetes and Osteoporosis Center PA

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Idaho Falls : Investigational Site Number 840167

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Idaho Falls : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Nampa : Investigational Site Number 840163

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Illinois

Chicago : Cedar-Crosse Research Center

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

Springfield : Investigational Site Number 840162

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Indiana

Indianapolis : Riley Hospital for Children, Indiana University

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Avon : Investigational Site Number 840172

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Indianapolis : Investigational Site Number 840197

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Iowa

Iowa City : University of Iowa

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

Iowa City : University of Iowa Health Care

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Des Moines : Investigational Site Number 840108

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Iowa City : Investigational Site Number 840407

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Kansas

Overland Park : Vince And Associates Clinical Research

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Topeka : Investigational Site Number 840170

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Wichita : MidAmerica Diabetes Associates, PA

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Wichita : Investigational Site Number 840129

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Kentucky

Lexington : Kentucky Diabetes

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Lexington : Central Kentucky Research Associates, Inc.

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Lexington : Investigational Site Number 840421

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Lexington : Kentucky Diabetes Endocrinology Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Louisiana

Metairie : Investigational Site Number 840426

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

New Orleans : Louisiana Research Associates, Inc.

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

New Orleans : Investigational Site Number 840164

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Maryland

Baltimore : University of Maryland Medical Center

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

Baltimore : University of Maryland Medical Center

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Rockville : Diabetes & Glandular Disease Research

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Rockville : Investigational Site Number 840180

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Massachusetts

Boston : Massachusetts General Hospital

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

Boston : Joslin Diabetes Center

Study to Prevent Kidney Disease in Type 1 Diabetes

Boston : Massachusetts General Hospital

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

Boston : Joslin Diabetes Center

TrialNet Natural History Study for the Prevention of Type 1 Diabetes

Worcester : UMASS Memorial Medical Center

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

View More »

Boston : Investigational Site Number 840409

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Boston : Massachusettes General Hospital/ Diabetes Research Center

Comparison of Lantus and NPH Insulin in the Dawn Phenomenon

Boston : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Haverhill : Investigational Site Number 840137

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Michigan

Ann Arbor : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Detroit : Henry Ford Health System

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Detroit : Investigational Site Number 840408

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Kalamazoo : Jasper Clinic, Inc.

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Madison Heights : Investigational Site Number 840153

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Minnesota

Minneapolis : University of Minnesota

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Rochester : Mayo Clinic

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

St Louis Park : Investigational Site Number 840171

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Missouri

Hazelwood : Healthcare Research Network

Do you have Diabetic Foot Pain? Are you 18+ years old? If so, you may qualify for our study! Call us today to find out more information.

Kansas City : Children’s Mercy Hospital

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

Kansas City : The Children’s Mercy Hospital

T1DAL: Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

Kansas City : Dybedal Clinical Research Center

Type 1 Diabetes

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Young Adults Are Needed for a Research Study on Type 1 Diabetes at Washington University.

View More »

Kansas City : Kansas City University Of Medicine And Biosciences

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

St Louis : Investigational Site Number 840184

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

St. Louis : Washington University

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Montana

Billings : Investigational Site Number 840406

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Billings : Billings Clinic Research Center

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

Butte : Mercury Street Medical

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Nebraska

Omaha : Creighton University

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Omaha : Investigational Site Number 840106

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Omaha : Investigational Site Number 840145

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Omaha : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Nevada

Henderson : Desert Endocrinolgy

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Las Vegas : Investigational Site Number 840139

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Las Vegas : Palm Medical Research Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Las Vegas : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

New Jersey

Hackensack : Advanced Biomedical Research, Inc. (ABR)

Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes

New Mexico

Albuquerque : Investigational Site Number 840151

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Santa Fe : Soutwest Clinical Research Center, LLC

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

New York

Bronx : Einstein-Montefiore Institute for Clinical & Translational Research

Exenatide (Byetta) vs Pramlintide (Symlin) Role in Post-Prandial Hyperglycemia

Bronx : Einstein-Montefiore Institute for Clinical & Translational Research

New Onset Type 1 Diabetes: Role of Exenatide

Bronx : Biomedical Research Alliance of New York

Type 1 Diabetes- two different insulin treatments.

New York : Naomi Berrie Diabetes Center

Proleukin and Rapamune in Type 1 Diabetes

New York : Naomi Berrie Diabetes Center at Columbia University Medical Center

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

New York : Columbia University

The ACCESS Trial for lupus with kidney disease (lupus nephritis)

Rochester : University of Rochester Medical Center, Strong Children’s Research Center

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Bronx : Albert Einstein College of Medicine West Campus CRC

Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting

New Hyde Park : Investigational Site Number 840191

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

New Hyde Park : North Shore Diabetes and Endocrine Associates

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

New York : MedHex Health

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

New York : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Syracuse : Research Foundation of SUNY Upstate Medical University

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Syracuse : Investigational Site Number 840173

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Williamsville : Diabetes-Endocrinology Center of Western NY

Liraglutide in the Treatment of Type 1 Diabetes Mellitus

North Carolina

Durham : University of North Carolina, Diabetes Care Center

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Asheville : Investigational Site Number 840133

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Ashville : Mountain Diabetes and Endocrine Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Chapel Hill : Investigational Site Number 840175

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Durham : University of North Carolina Diabetes Care Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Greensboro : Investigational Site Number 840142

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Mooresville : Investigational Site Number 840154

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Morehead City : Diabetes & Endocrinology Consultants, PC

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Morganton : Investigational Site Number 840161

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Ohio

Cincinnati : Community Research

Diabetic struggling with your weight?

Columbus : Nationwide Children’s Hospital

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

View More »

Cincinnati : Sentral Clinical Research Services, LLC

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Cincinnati : The Lindner Research Center, The Christ Hospital

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Cleveland : Cleveland Clinic

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Mentor : Investigational Site Number 840169

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Oklahoma

Norman : Investigational Site Number 840119

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Oregon

Bend : Investigational Site Number 840112

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Portland : Oregon Health Sciences University

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Portland : Research Site Updated

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Portland : Legacy Clinical Research & Technology Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Pennsylvania

Philadelphia : Children’s Hospital of Philadelphia

RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes

Philadelphia : Children’s Hospital of Philadelphia

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Philadelphia : Investigational Site Number 840128

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Philadelphia : Nemours Children's Clinic-Jefferson

Statins in Children With Type 1 Diabetes and Hypercholesterolemia

South Carolina

Greer : Investigational Site Number 840136

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

South Dakota

Dakota Dunes : Investigational Site Number 840122

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Rapid City : Regional Medical Clinic-Endocrinology

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Tennessee

Bartlett : AM Diabetes & Endocrinology Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Chattanooga : Investigational Site Number 840144

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Nashville : Investigational Site Number 840187

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Texas

Dallas : University of Texas Southwestern

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Austin : Texas Diabetes and Endocrinology

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Austin : Investigational Site Number 840109

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Austin : Investigational Site Number 840157

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Dallas : Baylor Endocrine Center

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Dallas : Research Institute of Dallas

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Dallas : Dallas Diabetes and Endocrine Research Center

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Dallas : Mountain Diabetes & Endrocrine Center

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Dallas : Dallas Diabetes & Endocrine Center

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Dallas : Investigational Site Number 840412

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Dallas : Investigational Site Number 840150

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Dallas : Diabetech

Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes

Dallas : UT Southwestern Medical Center

Effects of Metreleptin in Type 1 Diabetes Mellitus

Dallas : Research Institute of Dallas

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Dallas : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Dallas : Lexicon Investigational Site

Safety and Efficacy of LX4211 in Patients With Inadequately Controlled Type 1 Diabetes Mellitus

Houston : Investigational Site Number 840141

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Houston : Investigational Site Number 840130

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Houston : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Round Rock : Texas Diabetes and Endocrinology

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

San Antonio : Sonterra Clinical Research

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

San Antonio : Investigational Site Number 840166

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

San Antonio : Cetero Research

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

San Antonio : SAM Clinical Research Center

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

San Antonio : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Utah

Murray : Radiant Research - Salt Lake City

Clinical Research Study for Type 1 Diabetics

Murray : Radiant Research

Diabetes (Type 1) Research Study

View More »

Murray : Investigational Site Number 840101

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Virginia

Burke : Investigational Site Number 840125

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Charlottesville : University of Virginia Center for Diabetes Technology

Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes

Charlottesville : University of Virginia

Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker

Chesapeake : Investigational Site Number 840427

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Manassas : Investigational Site Number 840103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Washington

Renton : Rainier Clinical Research Center, Inc.

Do you have Type 1 Diabetes? Rainier Clinical Research Center is seeking participants who have been diagnosed with type 1 diabetes and are interested in participating in a study of a new investigational insulin

Seattle : Benaroya Research Institute at Virginia Mason Research Center

T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept

View More »

Olympia : Capital Clinical Research Center

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Renton : Ranier Clinical Research, Inc

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

Renton : Investigational Site Number 840132

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Seattle : Investigational Site Number 840403

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Seattle : Seattle Children's Hospital

The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children

Spokane : Investigational Site Number 840402

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Spokane : Northside Internal Medicine Associates, PS

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Tacoma : Investigational Site Number 840127

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Tacoma : Chous Eye Care Associates

Diabetes Visual Function Supplement Study

Tacoma : Multicare Specialties Research

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Wisconsin

Madison : University of Wisconsin

Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients

Milwaukee : Investigational Site Number 840411

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Argentina

San Martin : Hospital Interzonal General de Agudos Eva Perón

Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus

Australia

Perth : University of Western Australia

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial

Austria

Graz :

A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes

Graz : Medical University of Graz

Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes

Innsbruck : Universitatsklinik fur Innere Medzin I, Landeskrankenhaus

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Vienna : Rudolfstiftung Hospital

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Belarus

Minsk : Belarusian Medical Academy of Postgraduate Education

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Minsk : Endocrinological Unit 1st City Clinical Hospital

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Minsk : Health Institution City Endocrinological Dispensary

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Minsk : Republican center of Medical Rehabilitation and Balneotherapy

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Mogilov : Health Institution Mogilev Diagnostic Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Brazil

Ribeirão Preto : Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus

Canada

Calgary : LMC Endocrinology Centres

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Calgary : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Coquitlam : Investigational Site Number 124110

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Laval : Investigational Site Number 124104

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Laval : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

View More »

Mirabel : Investigational Site Number 124108

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Montreal : Investigational Site Number 124109

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Montreal : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Oakville : LMC Endocrinology Centres

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Thornhill : Investigational Site Number 124105

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Toronto : Hospital for Sick Children

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial

Toronto : Investigational Site Number 124101

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Toronto : LMC Endocrinoly Centres

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Toronto : Updated

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

China

Beijing : Investigational Site Number 156001

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

Beijing : Investigational Site Number 156006

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

Beijing : Investigational Site Number 156007

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

Changsha : Investigational Site Number 156009

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

Guangzhou : Investigational Site Number 156008

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

View More »

Hangzhou : Investigational Site Number 156004

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

Hangzhou : The First Affiliated Hospital of Zhejiang University

Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients

Jinan : General Hospital of Jinan Military Command

Stem Cell Educator Therapy in Type 1 Diabetes

Shanghai : Investigational Site Number 156016

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

Shanghai : Investigational Site Number 156005

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

Taiyuan : Investigational Site Number 156019

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

Wuhan : Investigational Site Number 156002

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

Czech Republic

Brno : Investigational Site Number 203102

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Prague : Fakultni nemocnice Kralovske Vinohrady - II. internal department

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Prague : IKEM/Diabetes Centre/Videnska

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Praha 10 : Investigational Site Number 203104

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Praha 8 : Investigational Site Number 203103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Denmark

Ålborg : Investigational Site Number 208102

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Århus C :

A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes

Esbjerg : Investigational Site Number 208103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Gentofte : Investigational Site Number 208105

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Gentofte : Steno Diabetes Center

Effect of CSII and CGM on Progression of Late Diabetic Complications

View More »

Hillerød : Hillerod Hospital

Recurrent Hypoglycaemia in Type 1 Diabetes

København Nv : Investigational Site Number 208104

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Køge : Investigational Site Number 208107

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Estonia

Pärnu : Investigational Site Number 233104

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Tallinn : Investigational Site Number 233105

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Tartu : Investigational Site Number 233106

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Tartu : Investigational Site Number 233101

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Viljandimaa : Investigational Site Number 233103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Finland

Kokkola : Investigational Site Number 246102

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Kuopio : Investigational Site Number 246101

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Loimaa : Investigational Site Number 246106

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Oulu : Investigational Site Number 246105

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Oulu : Tutkimusyksikko

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

View More »

Tampere : Investigational Site Number 246103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

France

Caen : CHU Côte de Nacre

Obtain a Good Blood Glucose Control With the Paradigm Real Time System

Dommartin les Touls : Hôpital Jeanne D'Arc

Obtain a Good Blood Glucose Control With the Paradigm Real Time System

Lyon : Hôpital Universitaire Debrousse

Obtain a Good Blood Glucose Control With the Paradigm Real Time System

Marseille : Hôpital Sainte Marguerite

Obtain a Good Blood Glucose Control With the Paradigm Real Time System

Montpellier : CH La Peyronie

Obtain a Good Blood Glucose Control With the Paradigm Real Time System

View More »

Paris : Hotel Dieu Hospital

Diagnosis and Physiopathology of Insulin Allergy

Reims : American Memorial Hospital

Obtain a Good Blood Glucose Control With the Paradigm Real Time System

Toulouse : UH Toulouse

Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy

Toulouse : CHU Rangueil

Obtain a Good Blood Glucose Control With the Paradigm Real Time System

Germany

Bad Mergentheim : Bad Mergentheim

The InsuPad in Daily Life Study

Dusseldorf : DDZ Studienzentrum Deutsches Diabetes Zentrum

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Giessen : Universitatsklinikum Giessen

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Hannover : Diabetes Centre for Children and Adolescents, Kinderkrankenhaus auf der Bult

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Munchen : Institut für Diabetesforschung an der Klinik und Hochschulambulanz für Kinder- und Jugendmedizin

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

View More »

Munster : Institut für Diabetesforschung Münster GmbH

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Neuss : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes

Neuss :

A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes

Hungary

Budapest : Investigational Site Number 348103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Budapest : Investigational Site Number 348108

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Budapest : Investigational Site Number 348107

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Debrecen : Investigational Site Number 348106

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Gyula : Investigational Site Number 348102

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

View More »

Szeged : University of Szeged Faculty of Medicin

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Urhida : Investigational Site Number 348101

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Veszprem : Veszprem Megyei Csolnoky Ferenc Korhaz es Rendelointezet Diabetologia Centrum

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Zalaegerszeg : Zala Megyei Korhaz es Rendelointezet Diabetologia Centrum

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

India

Bangalore : Diacon Hospital,(Diabetes Care and Research Centre)

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

Bangalore : Bangalore Diabetes Hospital

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

Karnal : Bharti Research Institute of Diabetes and Endocrinology

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

Israel

Beer Sheva : Diabetes Clinic Soroka University

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Beer Sheva : Soroka University Medical Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Beer-Sheva : Soroka University Medical Center

Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device

Haifa : Rambam Medical Cent

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Holon : Wolfson Medical Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

View More »

Jerusalem : Hadassah Medical Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Jerusalem : Hadassah Medical Organization

Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring Device

Petach Tikva : Schneider Medical Center

Performance Study of the SOLO 2.0 Insulin Pump

Petach-Tiqva : Institute for Endocrinology and Diabetes Schneider Children's MC

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Tel Aviv : Sourasky Medical Center,

Performance Study of the SOLO 2.0 Insulin Pump

Zerifin : Assaf-Harofeh Medical Center

Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study

Italy

Grosseto : P.O. di Grosseto - Stabilimento Misericordia

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

Mariano Comense : Az. Osp. S. Anna - Presidio Ospedaliero Cantù - Mariano Comense

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

Milan : Istituto Scientifico San Raffaele

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

Milan : Ospedale Niguarda Cà Granda

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

Naples : II Università di Napoli Centro Regionale di Diabetologia Pediatrica "G. Stoppoloni"

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

View More »

Padua : Università degli Studi di Padova Dipartimento di Medicina Clinica e Sperimentale

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

Palermo : . Endocrinologia e Malattie Metaboliche, Dipartimento biomedico di medicina interna e specialistica, Ex Istituto di clinica medica, Università di Palerm

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Pisa : Ospedale Cisanello

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

Ravenna : U.O. di Diabetologia, Dip. di Malattie Digestive & Metaboliche

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

Rome : University La Sapienza, Policlinico Umberto I

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Rome : Dept. of Endocrinology and Diabetes University Campus Bio-Medico

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Rome : Ospedale Sandro Pertini

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

Turin : Azienda Ospedaliera-Universitaria S. Giovanni Battista

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

Japan

Aisai-Shi : Investigational Site Number 392110

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Amagasaki-Shi : Investigational Site Number 392119

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Chuo-Ku : Investigational Site Number 392106

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Chuo-Ku : Investigational Site Number 392107

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Ebina-Shi : Investigational Site Number 392110

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

View More »

Higashiosaka-Shi : Investigational Site Number 392115

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Ise-Shi : Investigational Site Number 392105

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Izumisano-Shi : Investigational Site Number 392117

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Kamakura-Shi : Investigational Site Number 392109

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Karatsu-Shi : Investigational Site Number 392104

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Kitakyushu-Shi : Investigational Site Number 392111

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Koriyama-Shi : Investigational Site Number 392101

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Kumamoto-Shi : Investigational Site Number 392001

Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus

Kurashiki-Shi : Investigational Site Number 392121

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Matsumoto-Shi : Investigational Site Number 392112

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Matumoto : Investigational Site Number 392108

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Midori-Shi : Investigational Site Number 392103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Mito-Shi : Investigational Site Number 392107

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Nagoya-Shi : Investigational Site Number 392112

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Nishinomiya-Shi : Investigational Site Number 392120

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Osaka-Shi : Investigational Site Number 392113

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Osaka-Shi : Investigational Site Number 392116

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Osaka-Shi : Investigational Site Number 392118

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Sakai-Shi : Investigational Site Number 392101

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Shinjuku-Ku : Investigational Site Number 392104

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Shinjuku-Ku : Investigational Site Number 392105

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Shizuoka-Shi : Investigational Site Number 392111

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Takatsuki-Shi : Investigational Site Number 392114

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Tokushima-Shi : Investigational Site Number 392122

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Tomioka-Shi : Investigational Site Number 392103

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Tomishiro : Investigational Site Number 392102

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Ushiku-Shi : Investigational Site Number 392102

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Yamagata-Shi : Investigational Site Number 392106

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Yokohama-Shi : Investigational Site Number 392108

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus

Latvia

Limbazi : Investigational Site Number 428106

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Riga : Investigational Site Number 428103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Riga : Investigational Site Number 428105

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Sigulda : Investigational Site Number 428102

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Ventspils : Investigational Site Number 428101

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Lithuania

Jonava : Private Clinic JSC 'Kristavita'

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Kaunas : Kaunas Medical University Hospital

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Vilnius : Vilnius Medical University Hospital, Santariskiu Clinic's

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Vilnius : Public Institution 'Seskines Outpatient Clinic'

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Netherlands

Almere : Investigational Site Number 528101

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Beek : Investigational Site Number 528103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Nijmegen : Investigational Site Number 528105

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Venlo : Investigational Site Number 528104

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Zwijndrecht : Investigational Site Number 528102

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Philippines

Makati City : Beverly Hills Medical Group

Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes

Quezon City : Veterens Memorial Medical Centre

Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes

Poland

Lodz : NZOZ OmniMed

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Puerto Rico

Ponce : Investigational Site Number 840602

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Ponce : Investigational Site Number 840601

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Romania

Bacau : Investigational Site Number 642107

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Brasov : Investigational Site Number 642103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Oradea : Investigational Site Number 642109

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Resita : Investigational Site Number 642106

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Sibiu : Investigational Site Number 642104

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

View More »

Targu Mures : Investigational Site Number 642101

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Targu Mures : Investigational Site Number 642102

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Timisoara : Investigational Site Number 642108

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Timisoara : Investigational Site Number 642105

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Russian Federation

Chelyabinsk : State Educational Institution for Additional Professional Education (SEIAPE) "Ural State Medical

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Kemerovo : Kemerovo Regional Clinical Hospital

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Moscow : City Clinical Hospital #81, Endocrinology Department

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Moscow : Endocrinological scientific center of Rosmedtechnology

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Moscow : Clinic of New Medical Technology, LLC

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

View More »

Moscow : SEIAPE Endocrinology and Diabetology

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Nizhni Novgorod : State Healthcare Institution (SHI) "Nizhegorodskaya

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Perm : State Healthcare Institution Perm Region Clinical Hospital

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Samara : Limited Liability Company (LLC), Diabetes Center

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

St Petersburg : State Educational Institution of Higher Professional Education

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

St. Petersburg : St. Petersburg State Healthcare Institution

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Tomsk : Siberian State Medical University of Roszdrav

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Spain

Las Palmas de Gran Canaria : Complejo Hospitalario Universitario Insular Materno-Infantil

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Lleida : Hospital Universitari Arnau de Vilanova

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Oviedo : Hospital Universitario Central de Asturias

Stem Cell Educator Therapy in Type 1 Diabetes

Sweden

Goteborg : Investigational Site Number 752103

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Kristianstad : Investigational Site Number 752105

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Stockholm : Investigational Site Number 752101

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Vällingby : Investigational Site Number 752104

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Switzerland

Basel : University Hospital Basel

Effects of XOMA 052 on Insulin Production in Type 1 Diabetes

United Kingdom

Cambridge : Cambridge University Hospitals NHS Foundation Trust

Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes

Glasgow :

REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

High Wycombe : Wycombe Hospital

Comparing Long-acting Insulins During Exercise in Type 1 Diabetes

Swansea : Clinical Research Unit

Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)